Back
Dermata Therapeutics, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
26
DRMA
Dermata Therapeutics, Inc.
Last Price:
$2.14
Seasonality Move:
-34.61%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.
Dermata Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Buy |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.81 | Sell |
| 200-day SMA: | 5.85 | Sell |
| 8-day EMA: | 2.2 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.91 | Sell |
| 200-day EMA: | 8.73 | Sell |
Dermata Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 41.79 | Sell |
| Chaikin Money Flow: | -17173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.11 - 2.79) | Sell |
| Bollinger Bands (100): | (2.68 - 5.24) | Sell |
Dermata Therapeutics, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics, Inc. Stock
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 2.14 while DRMA 8-day simple moving average is 2.14, which is a Buy signal.
-
The stock price of DRMA is 2.14 while Dermata Therapeutics, Inc. 20-day SMA is 2.35, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day simple moving average is 2.81 while DRMA share price is 2.14, making it a Sell technically.
-
DRMA stock price is 2.14 and Dermata Therapeutics, Inc. 200-day simple moving average is 5.85, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
26
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Is Dermata Therapeutics, Inc. a Buy or a Sell?
-
Dermata Therapeutics, Inc. stock is rated a SellThe current Dermata Therapeutics, Inc. [DRMA] share price is $2.14. The Score for DRMA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics, Inc. Stock Info
Market Cap:
2.2M
Price in USD:
2.14
Share Volume:
63K
Dermata Therapeutics, Inc. 52-Week Range
52-Week High:
23.70
52-Week Low:
1.58
Sell
26
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Dermata Therapeutics, Inc. Share Price Forecast
-
What is the Dermata Therapeutics, Inc. stock price today?The Dermata Therapeutics, Inc. stock price is 2.14 USD today.
-
Will DRMA stock go up or go down?Dermata Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dermata Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics, Inc. is overvalued.
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 2.14 while DRMA 8-day exponential moving average is 2.20, which is a Sell signal.
-
The stock price of DRMA is 2.14 while Dermata Therapeutics, Inc. 20-day EMA is 2.35, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day exponential moving average is 2.91 while DRMA share price is 2.14, making it a Sell technically.
-
DRMA stock price is 2.14 and Dermata Therapeutics, Inc. 200-day simple moving average is 8.73, creating a Sell signal.
Technical Analysis of Dermata Therapeutics, Inc.
Should I short Dermata Therapeutics, Inc. stock?
-
DRMA Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Dermata Therapeutics, Inc. is a Sell
-
Dermata Therapeutics, Inc. Relative Strength Index (RSI) is 41.79, which suggest Dermata Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Dermata Therapeutics, Inc. is (2.11 - 2.79), which suggest Dermata Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Dermata Therapeutics, Inc. is (2.68 - 5.24), which suggest Dermata Therapeutics, Inc. is a Sell
* Dermata Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.